In contrast, TNFRSF14 binding in cis to BTLA inhibits trans interactions with LIGHT, LTA, or CD160, to maintain NK cells and T lymphocytes in a resting state, thus tuning lymphocyte activation to the surrounding tumor microenvironment (47). The gene discussed is CD160; the disease is neoplasm.